SUMIT SHARMA

SUMIT SHARMA

0
Followers
5
Following
DELHI NCR
SUMIT SHARMA
More ideas from SUMIT
Subcutaneous Rituximab Approved by FDA for Blood Cancers  Subcutaneous rituximab (Rituxan Hycela) has been approved by the FDA for the treatment of adults with previously untreated and relapsed or refractory follicular lymphoma, previously untreated diffuse large B-cell lymphoma (DLBCL), and previously untreated and previously treated chronic lymphocytic leukemia (CLL).  “With today’s approval of Rituxan Hycela, people with 3 of the most common blood cancers now have a new treatment option…

Subcutaneous Rituximab Approved by FDA for Blood Cancers Subcutaneous rituximab (Rituxan Hycela) has been approved by the FDA for the treatment of adults with previously untreated and relapsed or refractory follicular lymphoma, previously untreated diffuse large B-cell lymphoma (DLBCL), and previously untreated and previously treated chronic lymphocytic leukemia (CLL). “With today’s approval of Rituxan Hycela, people with 3 of the most common blood cancers now have a new treatment option…

WORLD SICKLE CELL DAY  World Sickle Cell Day comes on June 19 of every year. Sickle Cell Disease is an inheritable, genetic and fatal disease causing red blood cells disorders which have been classified as sickle cell anemia and it may lead to death. World Sickle Cell Day is observed to cover all the curable standards through the fast awareness program to take this genetic health condition under control across the world. The variety of promotional activities will be conducted by the WHO…

WORLD SICKLE CELL DAY World Sickle Cell Day comes on June 19 of every year. Sickle Cell Disease is an inheritable, genetic and fatal disease causing red blood cells disorders which have been classified as sickle cell anemia and it may lead to death. World Sickle Cell Day is observed to cover all the curable standards through the fast awareness program to take this genetic health condition under control across the world. The variety of promotional activities will be conducted by the WHO…

Why is one twin smaller than the other? Answer could lie in the placenta MRI study finds differences in prenatal oxygen transport from mother to baby  When a baby is born small, it's often attributed to genetic factors or maternal risk factors like poor nutrition or smoking. But a twin study now finds that slower transport of oxygen from mother to baby across the placenta predicts slower fetal growth, as well as a smaller brain and liver.  This is the first study to make a direct connection…

When a baby is born small, it’s often attributed to genetic factors or maternal risk factors like poor nutrition or smoking.

Avelumab/Axitinib Combo Shows Encouraging Activity in Frontline RCC  The combination of the PD-L1 inhibitor avelumab (Bavencio) with the VEGF inhibitor axitinib (Inlyta) induced a response rate of 58.2% as a frontline regimen for advanced renal cell carcinoma (RCC), according to findings from the phase Ib JAVELIN Renal 100 trial presented at the 2017 ASCO Annual Meeting.

Do new drugs slow advanced kidney cancer? Kidney Cancer is one of the diseases which cannot be cured so easily. Pazopanib (Votrient) is the new drug

Epacadostat/ Nivolumab Combo Active in Melanoma, Head and Neck Cancer  Combining the IDO inhibitor epacadostat with nivolumab (Opdivo) demonstrated promising signs of activity for patients with squamous cell carcinoma of the head and neck (SCCHC) and those with melanoma, according to findings from the phase I/II ECHO-204 study presented at the 2017 ASCO Annual Meeting.

Throat cancer causes a series of signs and symptoms. The symptoms depend on the exact location of th.

Compounds of Anti-Tumor Variations Highly Potent Against Cancer Cells Scientists have identified some of the most potent epothilones to date, which proved to be highly effective in killing cancer cells, including a drug-resistant cell line.  The cancer-fighting mechanisms of these substances are similar to paclitaxel, but have superior properties. Epothilones interfere with tubulin proteins that form the cells’ skeletal microtubules to prevent cancer cells from dividing.

Compounds of Anti-Tumor Variations Highly Potent Against Cancer Cells Scientists have identified some of the most potent epothilones to date, which proved to be highly effective in killing cancer cells, including a drug-resistant cell line. The cancer-fighting mechanisms of these substances are similar to paclitaxel, but have superior properties. Epothilones interfere with tubulin proteins that form the cells’ skeletal microtubules to prevent cancer cells from dividing.

Brain cancer can now be detected five years earlier in blood: Study  Interactions among proteins that relay information from one immune cell to another are weakened in the blood of brain cancer patients within five years before the cancer is diagnosed  The study, published in the journal PLOS ONE, focused on gliomas, which make up about 80 percent of brain cancer diagnoses. Average survival time for the most common type of glioma is 14 months.  Symptoms vary and include headaches, memory…

Brain cancer can now be detected five years earlier in blood: Study Interactions among proteins that relay information from one immune cell to another are weakened in the blood of brain cancer patients within five years before the cancer is diagnosed The study, published in the journal PLOS ONE, focused on gliomas, which make up about 80 percent of brain cancer diagnoses. Average survival time for the most common type of glioma is 14 months. Symptoms vary and include headaches, memory…